This article first appeared on GuruFocus.

LifeMD Inc (NASDAQ:LFMD) is set to release its Q3 2025 earnings on Nov 6, 2025. The consensus estimate for Q3 2025 revenue is $62.06 million, and the earnings are expected to come in at -$0.05 per share. The full year 2025's revenue is expected to be $253.08 million and the earnings are expected to be -$0.14 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 4 Warning Signs with LFMD.

Is LFMD fairly valued? Test your thesis with our free DCF calculator.

Over the past 90 days, revenue estimates for LifeMD Inc (NASDAQ:LFMD) have declined from $267.86 million to $253.08 million for the full year 2025 and from $317.86 million to $296.57 million for 2026. Similarly, earnings estimates have decreased from $0.02 per share to -$0.14 per share for 2025 and from $0.29 per share to $0.23 per share for 2026.

In the previous quarter ending June 30, 2025, LifeMD Inc's (NASDAQ:LFMD) actual revenue was $62.22 million, which missed analysts' revenue expectations of $66.34 million by -6.22%. LifeMD Inc's (NASDAQ:LFMD) actual earnings were -$0.06 per share, which missed analysts' earnings expectations of -$0.006 per share by -900%. After releasing the results, LifeMD Inc (NASDAQ:LFMD) was down by -44.85% in one day.

Based on the one-year price targets offered by 8 analysts, the average target price for LifeMD Inc (NASDAQ:LFMD) is $12.88, with a high estimate of $18.00 and a low estimate of $8.00. The average target implies an upside of 137.55% from the current price of $5.42.

Based on GuruFocus estimates, the estimated GF Value for LifeMD Inc (NASDAQ:LFMD) in one year is $7.37, suggesting an upside of 35.98% from the current price of $5.42.

Based on the consensus recommendation from 8 brokerage firms, LifeMD Inc's (NASDAQ:LFMD) average brokerage recommendation is currently 2.0, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.